Physician

Alisa Yamasaki, M.D.

According to 2025 Medicare claims, Alisa Yamasaki, M.D. (NPI: 1184010415) practices otolaryngology in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY, PC (NPI: 1962977249; TIN: 232865181) and primary practice location at 08540-2859. Yamasaki is affiliated with the Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Yamasaki's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 249 traditional Medicare patients, billed 1,421 HCPCS/CPT codes, and received $112,063 in Medicare payments. The top billing code was 31231 (Diagnostic exam of nasal passages using an endoscope). Part D data shows 292 prescription claims across 165 beneficiaries totaling $9,711 in drug costs, led by Olopatadine Hcl (Olopatadine Hcl). DME data shows 27 claims. Open Payments data shows 2 records totaling $29. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,501 to $112,063. Similarly, Part D prescription costs have risen steadily, from $1,201 to $9,711. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	33	99	$9,501
2021	93	291	$30,369
2022	103	265	$29,415
2023	285	1,186	$103,070
2024	249	1,421	$112,063

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	34	47	$1,201
2016	49	86	$2,555
2017	66	106	$2,449
2018	40	65	$4,801
2019	28	35	$891
2020	29	48	$549
2021	71	121	$3,685
2022	74	127	$6,756
2023	168	344	$9,145
2024	165	292	$9,711

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	27	$775

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
31231	Diagnostic exam of nasal passages using an endoscope	138	181	$156
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	89	89	$130
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	160	271	$103
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	77	95	$75
69210	Removal of impacted ear wax	126	164	$29

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Olopatadine Hcl	Olopatadine Hcl	19	614	$1,164
Ipratropium Bromide	Ipratropium Bromide	40	2,144	$995
Mometasone Furoate	Mometasone Furoate	20	374	$345
Fluticasone Propionate	Fluticasone Propionate	23	870	$210
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	23	224	$210

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	27	$775

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$29	Optinose US, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alisa Yamasaki, M.D.?

Tedicare shows public-source Medicare data for Alisa Yamasaki, M.D. (NPI 1184010415), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alisa Yamasaki, M.D. have ACO affiliation data?

Alisa Yamasaki, M.D. is shown with ACO affiliation data for Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to Alisa Yamasaki, M.D.?

Alisa Yamasaki, M.D. is linked to CLINICAL HEALTH CARE ASSOCIATES OF NEW JERSEY, PC (billing NPI 1962977249) in the available physician profile data.

Does Alisa Yamasaki, M.D. have Open Payments data?

Alisa Yamasaki, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.